GLAS CIK: 1848731

Glass House Brands Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.3
FY22:
−40.8
FY23:
23.2
FY24:
28.4
FY25:
11.4
Change from FY21 to FY25
millions USD
FY21:
−112
FY22:
−29.2
FY23:
−12.7
FY24:
−10.3
FY25:
−27.7
Change from FY21 to FY25
millions USD
FY21:
181
FY22:
30.1
FY23:
7.87
FY24:
−13.7
FY25:
2.72
millions USD
FY21:
49.5
FY22:
−39.9
FY23:
18.4
FY24:
4.40
FY25:
−13.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−129
FY22:
−68.6
FY23:
10.9
FY24:
18.1
FY25:
−15.7

All amounts in millions USD Data source:SEC EDGAR